Autres langues Eurofarma Laboratórios S.A.

Actions

EUFA3

BREUFAACNOR4

Marché Fermé - Sao Paulo			Varia. 5j.	Varia. 1 janv.
- ^BRL	-.--%		-.--%	-

14/08	Eurofarma Laboratórios S.A. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
15/05	Eurofarma Laboratórios S.A. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

14/08	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
15/05	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026
26/03	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
23/01	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil
10/12	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors
14/11	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
21/10/25	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer
21/10/25	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform
22/08/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
16/05/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025
26/03/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024
17/03/25	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.
14/11/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
14/08/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
15/05/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024
27/03/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
27/03/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
15/11/23	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
29/09/23	Eurofarma Laboratórios S.A. acquired Genfar S.A. from Sanofi.
17/08/23	Abcuro, Inc. announced that it has received $155 million in funding from a group of investors
14/08/23	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
11/08/23	Abcuro, Inc. announced that it expects to receive $199.522752 million in funding from Redmile Group, LLC, and other investors
27/03/23	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
08/03/23	Eurofarma Laboratórios S.A. agreed to acquire Genfar S.A. from Sanofi for approximately ?300 million.
15/12/22	Eurofarma Laboratórios S.A. acquired Laboratório Canonne for BRL 725 million.